Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-25 @ 5:21 PM
Study NCT ID:
NCT01829503
Status:
COMPLETED
Last Update Posted:
2019-11-14
First Post:
2013-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Sponsor:
Annie Im, M.D.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-06
First Submit QC Date:
None
Study First Post Date:
2013-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-10-20
Results First Submit QC Date:
None
Results First Post Date:
2017-09-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-12
Last Update Post Date:
2019-11-14
Last Update Post Date Type:
ACTUAL